Skip to main content
Caplight Logo









StemRad

StemRad

Private
Tel AvivHealthcare & Life Scienceshttps://stemrad.com/

Last Round

Series C

Dec 4, 2017

Total Funding Raised

$6M

Company Overview

StemRad is a personal protective equipment company that develops and manufactures selective radiation shielding for first responders, military personnel, medical teams, and astronauts.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Defense Tech, Space Technology, Medical Imaging

Business Model

B2G

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

radiation protectionwearable radiation shieldselective shieldingpersonal protective equipmentPPEradiation geargamma radiation shielddefense techbone marrow protectionspace technologyAcute Radiation SyndromeARSfirst responder equipmentmedical devicesnuclear safety equipmentexoskeleton

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StemRad Comparables

Compare StemRad with similar companies based on industry and business-model similarity.

StemRad comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rampart IC
71%
TIDI Products
70%
Salus Scientific
62%

StemRad Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 4, 2017

Key People

Founding team and executive leadership

Oren Milstein

CEO And Chief Scientific Officer

Executive Team

StemRad Investors

Notable investors and investment history

StemRad investors
InvestorRounds
Drs. Kiran & Pallavi Patel Family OfficeVC Round
Wanaka Capital PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 58% MoM.

  • Jun 1, 2025

    Monthly visitors increased 72% MoM, reaching 9.8K.

Recent news

Latest coverage and updates

  • launchesAug 13, 2026

    StemRad Inc. launched AstroRad radiation-shielding vest on Dec 31st '22.

  • partners_withAug 13, 2026

    StemRad Inc. partnered with Lockheed Martin Corporation on Dec 31st '22.

StemRad Filings

Explore SEC and related filing metadata, where available.

StemRad filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about StemRad's valuation, stock price, and market status.

Is StemRad a public or private company?

StemRad is a private company.

What is the current stock price of StemRad?

StemRad is a private company with no public stock price. No recent secondary market data is available.

How much is StemRad worth (valuation)?

Valuation information for StemRad is not publicly available.

Can I buy StemRad stock?

StemRad shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was StemRad's last funding round?

StemRad's most recent funding round was Series C on December 4, 2017.

Who are the main investors in StemRad?

Key investors in StemRad include Drs. Kiran & Pallavi Patel Family Office.

Will StemRad IPO soon?

No public IPO plans have been announced for StemRad.

How can I track StemRad secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor StemRad's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range12
Year Founded2011
Last FundingDec 4, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?